40364_2021_273_MOESM8_ESM.pptx (59.39 kB)
Download file

Additional file 8 of Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

Download (59.39 kB)
presentation
posted on 25.03.2021, 08:40 authored by Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, Yoshimi Umezawa, Seiichi Takao, Satoshi Iwata, Osamu Hosono, Tetsuo Taguchi, Taketo Yamada, Nam H. Dang, Kei Ohnuma, Eric Angevin, Chikao Morimoto
Additional file 8: Table S7. Correlation between serum sCD26/DPP4 titer variation (%) and tumor volume change (%) or PFS (days) in 9 MM, male cases with Q2W administration by PPMC or SRDC analysis.

Funding

Japan Society for the Promotion of Science Ministry of Health, Labour and Welfare

History